Elite in Hepatitis B

Rong-nan N. Chien

Linkou Branch, 
Taoyuan, TNQ, TW 
Elite in Hepatitis B
Linkou Branch, 
Taoyuan, TNQ, TW 
OverviewLocationsClinical Research

Overview

Rong-nan Chien practices in Taoyuan, Taiwan. Chien is rated as an Elite expert by MediFind in the treatment of Hepatitis B. Their top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, Liver Transplant, and Hepatectomy.

Their clinical research consists of co-authoring 210 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 86 articles and participated in 1 clinical trial in the study of Hepatitis B.

Locations

Linkou Branch, Taoyuan, TNQ, Taiwan
Other Locations
Linkou Branch, Linkou, TPQ, Taiwan
Keelung Branch, Keelung, TNQ 20401, Taiwan
No. 222, Maijin Road, Keelung, TNQ, Taiwan
Kee Lung Branch, Keelung, TNQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dose and Multiple Doses of GSK3389404 in Chronic Hepatitis B Subjects
A Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dose and Multiple Doses of GSK3389404 in Chronic Hepatitis B Subjects
Enrollment Status: Completed
Publish Date: October 01, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Randomized, Multiple-dose, Double-blind, Placebo-controlled Study of JKB-122 to Assess Liver Tests in HCV Subjects Who Have Been Nonresponsive to Prior Interferon Based Therapies Either Alone or in Combination With Ribavirin
A Phase 2, Randomized, Multiple-dose, Double-blind, Placebo-controlled Study of JKB-122 to Assess Liver Tests in HCV Subjects Who Have Been Nonresponsive to Prior Interferon Based Therapies Either Alone or in Combination With Ribavirin
Enrollment Status: Terminated
Publish Date: July 21, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

210 Total Publications

Association of aspirin use alone with mortality and liver-related events in MASLD: a multi-institutional three-year study.
Association of aspirin use alone with mortality and liver-related events in MASLD: a multi-institutional three-year study.
Journal: Annals of medicine
Published: October 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chien's expertise for a condition
ConditionClose
View All 30 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile